Yiend, JH, Savulich, GJ & Shergill, SS 2017, 'Interpretation biases in clinical paranoiaClinical Psychological Science. DOI: 10.1177/2167702617718180

Orlov, ND, O’daly, O, Tracy, DK, Daniju, Y, Hodsoll, J, Valdearenas, L, Rothwell, J & Shergill, SS 2017, 'Stimulating thought: a functional MRI study of transcranial direct current stimulation in schizophreniaBrain. DOI: 10.1093/brain/awx170

Gee, SH, Shergill, SS & Taylor, DM 2017, 'Patient attitudes to clozapine initiationInternational Clinical Psychopharmacology. DOI: 10.1097/YIC.0000000000000188

Joyce, DW, Tracy, DK & Shergill, SS 2017, 'Are we failing clinical trials? A case for strong aggregate outcomesPsychological Medicine, pp. 1-10. DOI: 10.1017/S0033291717001726

Yiend, J, Trotta, A, Meek, C, Dzafic, I, Baldus, N, Crane, B, Kabir, T, Stahl, D, Heslin, M, Shergill, S, Mcguire, P & Peters, E 2017, 'Cognitive Bias Modification for paranoia (CBM-pa): study protocol for a randomised controlled trialTrials, vol 18, no. 1. DOI: 10.1186/s13063-017-2037-x

Martinelli, C, Rigoli, F, Averbeck, B & Shergill, SS 2017, 'The value of novelty in schizophreniaSchizophrenia Research. DOI: 10.1016/j.schres.2017.05.007

Kanaan, R, Picchioni, M, McDonald, C, Shergill, SS & McGuire, PK 2017, 'White matter deficits in schizophrenia are global and don't progress with ageThe Australian and New Zealand journal of psychiatry. DOI: 10.1177/0004867417700729

Foster*, J, Lally*, J, Bell, V & Shergill, SS 2017, 'Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasiaBritish Journal of Psychiatry Open , vol 3, no. 1, pp. 22. DOI: 10.1192/bjpo.bp.116.003467

Anderson, EJ, Tibber, MS, Schwarzkopf, DS, Shergill, S, Fernandez-Egea, E, Rees, G & Dakin, SC 2017, 'Visual population receptive fields in people with schizophrenia have reduced inhibitory surroundsJournal of Neuroscience, vol 37, no. 6, pp. 1546-1556. DOI: 10.1523/JNEUROSCI.3620-15.2016

Gee, SH, Taylor, DM, Shergill, SS, Flanagan, R & MacCabe, JH 2017, 'Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unitTherapeutic Advances in Psychopharmacology, vol 7, no. 2, pp. 79-83. DOI: 10.1177/2045125316677027

Joyce, DW, Kehagia, AA, Tracy, DK, Proctor, J & Shergill, SS 2017, 'Realising stratified psychiatry using multidimensional signatures and trajectoriesJournal Of Translational Medicine, vol 15, no. 1, 15. DOI: 10.1186/s12967-016-1116-1

Martinelli, C, Rigoli, F & Shergill, SS 2017, 'Aberrant force processing in schizophreniaSchizophrenia Bulletin, vol 43, no. 2, pp. 417-424. DOI: 10.1093/schbul/sbw092


Nalesnik, N, Tracy, DK, Joyce, D, Patel, S, Rodzinka-Pasko, J, Dolan, H, Hodsoll, J, Collier, T, Rothwell, J & Shergill, SS2016, 'Stimulating cognition in schizophrenia: A controlled pilot study of the effects of prefrontal transcranial direct current stimulation upon memory and learningBrain Stimulation. DOI: 10.1016/j.brs.2016.12.013

Vanes, LD, White, TP, Wigton, RL, Joyce, D, Collier, T & Shergill, SS 2016, 'Reduced susceptibility to the sound-induced flash fusion illusion in schizophreniaPsychiatry Research, vol 245, pp. 58-65. DOI: 10.1016/j.psychres.2016.08.016

Lally, J, Ajnakina, O, Di Forti, M, Trotta, A, Demjaha, A, Kolliakou, A, Mondelli, V, Reis Marques, T, Pariante, C, Dazzan, P, Shergill, SS, Howes, OD, David, AS, MacCabe, JH, Gaughran, F & Murray, RM 2016, 'Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychosesPsychological Medicine, vol 46, no. 15, pp. 3231-3240. DOI: 10.1017/S0033291716002014

Mallas, E-J., Carletti, F., Chaddock, C. A., Shergill, S., Woolley, J., Picchioni, M. M., ... Prata, D. P. (2016). The impact of CACNA1C gene, and its epistasis with ZNF804A, on white matter microstructure in health, schizophrenia and bipolar disorderGenes, Brain and Behavior10.1111/gbb.12355

Lage, C., Wiles, K., Shergill, S., & Tracy, D. K. (2016). A systematic review of the effects of low-frequency repetitive transcranial magnetic stimulation on cognitionJournal of neural transmission (Vienna, Austria : 1996), 1-12. 10.1007/s00702-016-1592-8

Vanes, L. D., White, T. P., Wigton, R. L., Joyce, D., Collier, T., & Shergill, S. S. (2016). Reduced susceptibility to the sound-induced flash fusion illusion in schizophreniaPsychiatry Research245, 58-65. 10.1016/j.psychres.2016.08.016

Gee, S. H., Shergill, S. S., & Taylor, D. M. (2016). Factors associated with changes in hospitalisation in patients prescribed clozapineJournal of psychopharmacology (Oxford, England)30(8), 819-825. 10.1177/0269881116642745

Martinelli, C., Rigoli, F., & Shergill, S. S. (2016). Aberrant force processing in schizophreniaSchizophrenia Bulletin.

Rigoli, F., Friston, K. J., Martinelli, C., Selakovic, M., Shergill, S. S., & Dolan, R. J. (2016). A Bayesian model of context-sensitive value attributionElife10.7554/eLife.16127

Lee, J-S., Mathews, A., Shergill, S., & Yiend, J. (2016). Magnitude of negative interpretation bias depends on severity of depressionBehaviour Research and Therapy10.1016/j.brat.2016.05.007

Fett, A. K. J., Shergill, S. S., Korver-Nieberg, N., Yakub, F., Gromann, P. M., & Krabbendam, L. (2016). Learning to trust: Trust and attachment in early psychosisPsychological Medicine46(7), 1437-1447. 10.1017/S0033291716000015

Kanaan, R. A., Allin, M., Picchioni, M. M., Shergill, S. S., & McGuire, P. K. (2016). White matter microstructural organization is higher with age in adult superior cerebellar pedunclesFrontiers in aging neuroscience8(APR), [71]. 10.3389/fnagi.2016.00071

Dyck, M. S., Mathiak, K. A., Bergert, S., Sarkheil, P., Koush, Y., Alawi, E. M., ... Mathiak, K. (2016). Targeting treatment-resistant auditory verbal hallucinations in schizophrenia with fMRI-based neurofeedback - exploring different cases of schizophreniaFrontiers in psychiatry / Frontiers Research Foundation7(MAR), [37]. 10.3389/fpsyt.2016.00037

Mallas, E-J., Carletti, F., Chaddock, C. A., Woolley, J., Picchioni, M., Shergill, S. S., ... Prata, D. P. (2016). Genome-wide discovered psychosis-risk gene ZNF804A impacts on white matter microstructure in health, schizophrenia and bipolar disorderPeerJ4, [e1570]. 10.7717/peerj.1570

White, T., Wigton, R., Joyce, D. W., Collier, T., Fornito, A., & Shergill, S. S. (2016). Dysfunctional Striatal Systems in Treatment-Resistant SchizophreniaNeuropsychopharmacology41, 1274–1285. 10.1038/npp.2015.277

Tracy, D. K., Smallcombe, N., Tiwana, F., Fosbraey, J., Sendt, K-V., & Shergill, S. (2016). The glutamate mGluR5 receptor as a pharmacological target to enhance cognitive function: emerging evidence from psychosis models. In F. López-Muñoz, V. Srinivasan, D. De Berardis, C. Álamo, & T. A. Kato (Eds.), Melatonin, neuroprotective agents and antidepressant therapy.. Berlin: Springer.


Al-Rifaie, M. M., Joyce, D., Shergill, S., & Bishop, M. (2015). Investigating stochastic diffusion search in data clustering. In IntelliSys 2015 - Proceedings of 2015 SAI Intelligent Systems Conference. (pp. 187-194). [7361143] Institute of Electrical and Electronics Engineers Inc.. 10.1109/IntelliSys.2015.7361143

White, T. P., Borgan, F., Ralley, O., & Shergill, S. S. (2015). You looking at me?: Interpreting social cues in schizophreniaPsychological Medicine10.1017/S0033291715001622

Gee, S., Dixon, T., Docherty, M., & Shergill, S. S. (2015). Optimising plasma levels of clozapine during metabolic interactions: A review and case report with adjunct rifampicin treatmentBMC Psychiatry15(1), [195]. 10.1186/s12888-015-0536-4

Martinelli, C., & Shergill, S. S. (2015). Clarifying the role of pattern separation in schizophrenia: the role of recognition and visual discrimination deficitsSchizophrenia Research166(1-3), 328-333. 10.1016/j.schres.2015.06.004

Tracy, D. K., Joyce, D. W., Sarkar, S. N., Mateos Fernandez, M. J., & Shergill, S. S. (2015). Skating on thin ice: Pragmatic prescribing for medication refractory schizophreniaBMC Psychiatry15(1), [174]. 10.1186/s12888-015-0559-x

Fusar-Poli, P., Papanastasiou, E., Stahl, D., Rocchetti, M., Carpenter, W. T., Shergill, S., & McGuire, P. (2015). Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled TrialsSchizophrenia Bulletin41(4), 892-899. 10.1093/schbul/sbu170

Martinelli, C., & Shergill, S. S. (2015). Everything you wanted to know about neuroimaging and psychiatry, but were afraid to askBJPsych Advances21(4), 251-260. 10.1192/apt.bp.114.013763

Fett, A. K. J., Shergill, S. S., & Krabbendam, L. (2015). Social neuroscience in psychiatry: Unravelling the neural mechanisms of social dysfunctionPsychological Medicine45(6), 1145-1165. 10.1017/S0033291714002487

Michalopoulou, P. G., Averbeck, B. B., Kalpakidou, A. K., Evans, S., Bobin, T., Kapur, S., & Shergill, S. S. (2015). The effects of a single dose of oxytocin on working memory in schizophreniaSchizophrenia Research162(1-3), 62-63. 10.1016/j.schres.2014.12.029

Tibber, M. S., Anderson, E. J., Bobin, T., Carlin, P., Shergill, S. S., & Dakin, S. C. (2015). Local and Global Limits on Visual Processing in SchizophreniaPLOS One, [0117951]. 10.1371/journal.pone.0117951

Beck*, K. E., Lally*, J. A., Shergill, S. S., Bloomfield, M. A. P., MacCabe, J. H., Gaughran, F. P., & Howes, O. (2015). Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosisBritish Journal of Psychiatry206(2), 164-165. 10.1192/bjp.bp.113.142216

Rowe, A., Mercer, L., Casetti, V., Sendt, K-V., Giaroli, G., Shergill, S., & Tracy, D. K. (2015). Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia.Journal of Psychopharmacology29(2), 197-211. 10.1177/0269881114564096

Lee, J. S., Mathews, A., Shergill, S., Chan, D. K. Y., Majeed, N., & Yiend, J. (2015). How Can We Enhance Cognitive Bias Modification Techniques?: The Effects of Prospective CognitionJournal of Behavior Therapy and Experimental Psychiatry10.1016/j.jbtep.2015.03.007

Meyer, N., Gee, S. H., Whiskey, E., Taylor, D. M., Mijovic, A., Gaughran, F. P., ... MacCabe, J. H.(2015). Optimising outcomes of clozapine rechallenge in patients with previous neurtrophenia: a cohort analysisJournal of Clinical Psychiatry.